1. Home
  2. PETS vs HYFT Comparison

PETS vs HYFT Comparison

Compare PETS & HYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PetMed Express Inc.

PETS

PetMed Express Inc.

N/A

Current Price

$2.31

Market Cap

61.6M

ML Signal

N/A

HYFT

MindWalk Holdings Corp.

N/A

Current Price

$1.16

Market Cap

69.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PETS
HYFT
Founded
1996
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Retail-Drug Stores and Proprietary Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
61.6M
69.6M
IPO Year
2003
N/A

Fundamental Metrics

Financial Performance
Metric
PETS
HYFT
Price
$2.31
$1.16
Analyst Decision
Sell
Analyst Count
1
0
Target Price
$3.20
N/A
AVG Volume (30 Days)
88.1K
339.4K
Earning Date
02-05-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
18.92
N/A
EPS
N/A
N/A
Revenue
$273,800,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.98
$51.71
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.57
$1.04
52 Week High
$4.32
$3.00

Technical Indicators

Market Signals
Indicator
PETS
HYFT
Relative Strength Index (RSI) 27.16 42.12
Support Level N/A $1.04
Resistance Level $2.93 $1.49
Average True Range (ATR) 0.12 0.11
MACD -0.01 0.02
Stochastic Oscillator 8.25 31.11

Price Performance

Historical Comparison
PETS
HYFT

About PETS PetMed Express Inc.

PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.

About HYFT MindWalk Holdings Corp.

MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.

Share on Social Networks: